Women Want Strong Men

Welcome to the Women Want Strong Men podcast. I’m your host Amy Stuttle. I believe it takes a strong man to appreciate a strong woman and I’m here t…
Nov 25th, 2022 | 16:06

Weight Loss Medication Update - Wegovy, Semaglutide, Mounjero, Trizapetide With Dr. David Yablonsky, DO - Fifteen On A Friday

Semaglutide has been proven to induce significant weight loss in patients.  This class of medication has been deemed a “game changer” and is changing the lives of patients needing to lose weight. Today we are going to give a quick recap on this class of medication and we are going to discuss Dr. Yablonsky’s clinical experience with this medication.  

Topics Discussed Include:

What is Semaglutide?
What weight loss medications are on the market?
Side effect profiles of the weight loss medication on the market?
How much does the drug cost? 
Clinical experience using Semaglutide
Tirzepatide brandname Mounjaro
Semaglutide brandname Ozempic or Wegovy 
The Hollywood “skinny shot” 

Studies:

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Tirzepatide Once Weekly for the Treatment of Obesity

Wegovy (semaglutide): a new weight loss drug for chronic weight management

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

More about Dr. Yablonsky:
Dr. David Yablonsky has been practicing medicine for over 20 years and is a board-certified internist. Dr. Yablonsky has experience in providing adults with help diagnosing a full range of medical issues including chronic disease management, primary care, hormone optimization, erectile dysfunction, weight loss and vitamin deficiencies. Dr. Yablonsky graduated with honors from Boston University prior to attending the Des Moines University College of Osteopathic Medicine. Upon completion of medical school, he went on to complete a three-year residency in Internal Medicine at the University of Rochester School of Medicine in Rochester, New York. His past leadership positions include Chief of Medicine, Internal Medicine Section Chief, Medical Director of Cardiopulmonary Rehabilitation and Chairman of Pharmacy and Therapeutics Committee at Grinnell Regional Medical Center in Grinnell, Iowa. Dr. Yablonsky’s focus is on disease prevention and health optimization. He has furthered his training by completing several conferences and courses in age management medicine including the elite training programs of Cenegenics, A4M, AMMG, and the International Peptide Society.

To learn more on this medication please see podcast episode 17
For questions about today's podcast you can contact Amy Stuttle at podcast@amystuttle.com
Click here to learn more about  Victory Men's Health

This podcast is not medical advice.